Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis - Wikidata - awgldk - TriplyDB

Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

http://www.wikidata.org/entity/Q40354067

about

Epidemiology and management of common pulmonary diseases in older persons The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Newer fluoroquinolones in the treatment of acute exacerbations of COPD Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.Optimizing antibiotic selection in treating COPD exacerbations Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysis Antibiotics in acute exacerbations of chronic bronchitis.Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.Pre-operative pulmonary assessment for patients with hip fracture.The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.Moxifloxacin: update and perspectives after 8 years of usage.Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.Appropriate antibiotic management of bacterial lower respiratory tract infections Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease Moxifloxacin: a respiratory fluoroquinolone

P2860

Q28397465-E9336D6A-DF32-4B15-8798-D0E6A9C0C59E Q33375205-520B3945-B49E-4B19-BFB4-9C702DDB33BD Q34075548-9A7B1EAB-4AD8-4FCB-9A72-E0522970866C Q34560033-CA097C2E-7810-4A4D-A2B6-18DAEC627120 Q35096997-6FE9D4E2-84FB-42C6-B4DF-B89843017D8D Q35694431-C7738158-8E2F-4FF5-8FC9-0CFCF9C43E91 Q36087058-51F7BFD6-AE54-4AD6-94A5-DBA9DF4BD25C Q37018822-2D32C19B-BAA4-41A3-8767-E60099F46C0E Q37071001-6C6D0125-E8AC-4C75-A948-DFE121BBD6E3 Q37167347-C7CF6FCA-E6B0-4A15-9A15-901CCB79287F Q37168358-07D6C543-A32C-475F-BCF7-EDAF7F32CF71 Q37629535-6351FC34-AAC9-43C0-9007-2A60E7DB0EE4 Q37727171-E64B3B05-BE80-4E93-9282-1B80DBF26E9B Q37798032-A91D96AC-87C4-4EB7-8E53-9681C1694D65 Q37807916-7E88D7E1-0F82-44D1-A978-37E86CFAF485 Q38056764-EEE041D6-B8EE-4BC5-A37A-2C03855D6041 Q43061626-7E26EB79-4871-474F-9600-9E08A0375DE6 Q43061662-C6A3362B-3741-45A5-A1A2-76FC0A97C953 Q43251154-B06E980F-685A-4845-86A5-81E6CFB5BC6E Q55400934-A6EFBC37-1807-42CD-8F9A-592DA9A04406 Q56942464-14FD8EAD-D046-404F-9CC9-693FE5C950DD Q57777851-DE97B09F-DF61-4FD7-8C83-98004DC1DEAF Q57778170-D1F955F0-F1A0-438D-B48E-18398637A642

P2860

Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

http://www.wikidata.org/entity/Q40354067

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Antibiotic treatment and facto ...... rbations of chronic bronchitis

@en

type

label

Antibiotic treatment and facto ...... rbations of chronic bronchitis

@en

prefLabel

Antibiotic treatment and facto ...... rbations of chronic bronchitis

@en

P1433

Q40354067-9356B4EE-5AE9-453D-B35E-1BC5015B0B97

P1476

Q40354067-B02E1248-A927-4662-AD3A-9AEBFBB1725C

P2093

Q40354067-05EF23C9-EB24-4A3B-AE6F-2448D00437C6

Q40354067-24AC3365-2C35-4DAD-9342-ACEF9E4EDC7F

Q40354067-6911022D-417D-4091-A6EA-0A2B0426E968

Q40354067-A4B5AE32-120F-489E-BBAD-01BD307597DD

Q40354067-C657937C-EA87-4707-B9C2-511DF687A282

Q40354067-CC66210F-C4F9-45FD-87F9-47B7E47AC337

Q40354067-CF32F9CC-6675-4806-B7A6-996E042E5EA6

P2860

Q40354067-02DF0583-F846-4926-87C0-49DF166B213E

Q40354067-087CC937-FCFB-4339-A1C2-D4EAE9378753

Q40354067-1631BCDD-01D5-474B-8BD9-68035FE39C79

Q40354067-1B168A82-8317-4923-BC07-6A6C5764DFC8

Q40354067-21A88E70-7444-4955-A90E-A3DE06E950DE

Q40354067-264A6A15-6BAE-481C-B9C8-E4546934D9E2

Q40354067-2C99C8D1-4B43-45CE-BA37-67D3B2575562

Q40354067-4B20366B-2B4C-4FFD-8DDB-D352C3F6884E

Q40354067-4F0151DD-DAC6-4748-977B-5D8B40D30385

Q40354067-507F60F0-DBA2-4292-BAC3-DE4014492663

P304

Q40354067-D3692908-ADC4-40C1-9D22-2CEF31DB02EB

P31

Q40354067-F3EF521A-BD6E-4942-BBEA-4E3537C88801

P356

Q40354067-D09084E7-2820-416D-8E5F-390A69923183

P407

Q40354067-98F0994E-347F-4724-99C9-715F61A38D2D

P433

Q40354067-C8445A6B-1710-4101-B05F-9B48A0FA8FAE

P478

Q40354067-7DAAF12A-0BF1-4F17-B791-D5DFB5400C9E

P577

Q40354067-9BC48B37-9A19-4FBF-8EAE-AF5773DDE4B5

P5875

Q40354067-4ABE7060-147F-45E3-BC3F-01DB4D66ABA2

P698

Q40354067-4EB4CB2A-1CAB-499D-913A-A2695EB181B4

P932

Q40354067-C7263591-1B7B-439B-90EF-B9581074BB72

P356

THX.2005.045930

P1433

P1476

Antibiotic treatment and facto ...... rbations of chronic bronchitis

@en

P2093

I Duprat-Lomon

http://www.w3.org/2001/XMLSchema#string

MOSAIC Study Group

http://www.w3.org/2001/XMLSchema#string

P Arvis

http://www.w3.org/2001/XMLSchema#string

P Jones

http://www.w3.org/2001/XMLSchema#string

P P Sagnier

http://www.w3.org/2001/XMLSchema#string

R Wilson

http://www.w3.org/2001/XMLSchema#string

T Schaberg

http://www.w3.org/2001/XMLSchema#string

P2860

The role of bacteria in exacerbations of COPD. A constructive view.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Canadian guidelines for the management of acute exacerbations of chronic bronchitis.

Bacteria, antibiotics and COPD.

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

Outcome predictors in bronchitis.

P304

337-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2005.045930

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7325251

http://www.w3.org/2001/XMLSchema#string

P698

16449273

http://www.w3.org/2001/XMLSchema#string

P932

2104610

http://www.w3.org/2001/XMLSchema#string